


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:51:29Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405948" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405948</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>ejprm</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Phys Rehabil Med</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Phys Rehabil Med</journal-id><journal-id journal-id-type="pmc-domain-id">4371</journal-id><journal-id journal-id-type="pmc-domain">ejprm</journal-id><journal-id journal-id-type="publisher-id">EJPRM</journal-id><journal-title-group><journal-title>European Journal of Physical and Rehabilitation Medicine</journal-title></journal-title-group><issn pub-type="ppub">1973-9087</issn><issn pub-type="epub">1973-9095</issn><publisher><publisher-name>Edizioni Minerva Medica S.p.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405948</article-id><article-id pub-id-type="pmcid-ver">PMC12405948.1</article-id><article-id pub-id-type="pmcaid">12405948</article-id><article-id pub-id-type="pmcaiid">12405948</article-id><article-id pub-id-type="pmid">40856378</article-id><article-id pub-id-type="doi">10.23736/S1973-9087.25.08770-2</article-id><article-id pub-id-type="publisher-id">8770</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Specialized orthotic care to improve functioning in adults with neuromuscular disorders: results of an open-label blinded end-point randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>VAN DUIJNHOVEN</surname><given-names initials="E">Elza</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup> 2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>KOOPMAN</surname><given-names initials="FS">Fieke S.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup> 2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>TUIJTELAARS</surname><given-names initials="J">Jana</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup> 2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>ALTMANN</surname><given-names initials="V">Viola</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>VAN DONGEN</surname><given-names initials="JM">Johanna M.</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>JANSE</surname><given-names initials="M">Manon</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>NOLLET</surname><given-names initials="F">Frans</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup> 2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>BREHM</surname><given-names initials="MA">Merel-Anne</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup> 2</sup>
</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib><aff><target id="aff1" target-type="aff"><sup>1</sup></target><institution content-type="dept">Department of Rehabilitation Medicine, Amsterdam UMC</institution>, <institution>University of Amsterdam</institution>, <addr-line>Amsterdam</addr-line>, <country country="nl">the Netherlands</country>; <target id="aff2" target-type="aff"><sup>2</sup></target><institution content-type="dept">Amsterdam Movement Sciences, Rehabilitation and Development</institution>, <addr-line>Amsterdam</addr-line>, <country country="nl">the Netherlands</country>; <target id="aff3" target-type="aff"><sup>3</sup></target><institution content-type="dept">Klimmendaal</institution>, <institution>Rehabilitation Center</institution>, <addr-line>Arnhem</addr-line>, <country country="nl">the Netherlands</country>; <target id="aff4" target-type="aff"><sup>4</sup></target><institution content-type="dept">Department of Health Sciences, Faculty of Science</institution>, <institution>Vrije Universiteit Amsterdam</institution>, <addr-line>Amsterdam</addr-line>, <country country="nl">the Netherlands</country>; <target id="aff5" target-type="aff"><sup>5</sup></target><institution>Reade Center for Rehabilitation and Rheumatology</institution>, <addr-line>Amsterdam</addr-line>, <country country="nl">the Netherlands</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author: Merel-Anne Brehm, Department of Rehabilitation Medicine, Amsterdam UMC, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands. E-mail: <email xlink:href="m.a.brehm@amsterdamumc.nl">m.a.brehm@amsterdamumc.nl</email></corresp><fn fn-type="con"><p><bold>Authors&#8217; contributions:</bold> Elza Van Duijnhoven wrote the manuscript and was, together with Jana Tuijtelaars, responsible for the data analysis. Johanna M. Van Dongen was responsible for cost-effectiveness analyses. Frans Nollet, and Merel-Anne Brehm initiated the study and made substantial contributions to the design of the study together with Fieke S. Koopman, Viola Altmann, Jana Tuijtelaars, and Elza Van Duijnhoven. Manon Janse was involved in providing orthotic care in one of the usual care centers. All authors conceived and approved the final version of the manuscript.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>61</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">496052</issue-id><fpage>496</fpage><lpage>508</lpage><history><date date-type="accepted"><day>13</day><month>6</month><year>2025</year></date><date date-type="rev-recd"><day>16</day><month>5</month><year>2025</year></date><date date-type="received"><day>04</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>2025 THE AUTHORS</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="12-8770-EJPRM_N_suppl.pdf"/><abstract><sec><title>BACKGROUND</title><p>People with neuromuscular disorders (NMD) are often provided with lower limb orthoses to improve walking. Guideline-based provision of lower limb orthoses in expert settings (<italic toggle="yes">i.e</italic>. specialized orthotic care) may improve treatment outcomes by better matching the orthotic properties to address walking problems in neuromuscular disorders (NMD).</p></sec><sec><title>AIM</title><p>We assessed the (cost)-effectiveness of specialized orthotic care compared to usual orthotic care in adults with NMD.</p></sec><sec><title>DESIGN</title><p>Randomized controlled trial with an economic evaluation.</p></sec><sec><title>SETTING</title><p>Outpatient rehabilitation settings.</p></sec><sec><title>POPULATION</title><p>Adults with plantar flexor and/or quadriceps weakness due to NMD with an indication for a lower limb orthosis.</p></sec><sec><title>METHODS</title><p>Participants were randomly assigned to specialized orthotic care (N.=31), or usual orthotic care (N.=30). Primary endpoints were personal goal attainment (at 24 weeks follow-up), and walking energy cost at comfortable speed (change from baseline to 24 weeks follow-up). Secondary endpoints included comfortable walking speed, spatiotemporal gait parameters, gait biomechanics, stability, physical functioning, (fear of) falling, fatigue and satisfaction.</p></sec><sec><title>RESULTS</title><p>Personal goal attainment was significantly higher for specialized orthotic care (P=0.011). Walking energy cost did not differ between groups (P=0.140) but decreased significantly with -11.8% (-0.55 J/kg/m; 95% CI: -0.99 to -0.11) following specialized, but not following usual orthotic care (-0.08 J/kg/m; 95% CI: -0.32 to 0.26). Secondarily, changes in step length, walking speed, physical functioning, and satisfaction were in favor of specialized orthotic care (P&#8804;0.042). Specialized orthotic care was likely cost-effective from a societal and healthcare perspective.</p></sec><sec><title>CONCLUSIONS</title><p>Specialized orthotic care was beneficial in attaining personal goals, and likely cost-effective compared to usual orthotic care.</p></sec><sec><title>CLINICAL REHABILITATION IMPACT</title><p>Guideline-based provision of lower limb orthoses in expert settings could enhance functioning of adults with NMD and generate societal cost savings.</p></sec></abstract><kwd-group kwd-group-type="author"><title>K<sc>ey</sc>
<sc>words</sc>: </title><kwd>Neuromuscular diseases</kwd><kwd>Foot orthoses</kwd><kwd>Cost-effectiveness analysis</kwd><kwd>Walking</kwd></kwd-group><funding-group><award-group><funding-source id="sp1">ZonMw, The Netherlands Organisation for Health Research and Development</funding-source><award-id rid="sp1">853001103</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>Walking difficulties due to lower limb muscle weakness are amongst the most frequently reported problems in people with neuromuscular disorders (NMD).<xref rid="r1" ref-type="bibr"><sup>1</sup></xref> Walking difficulties typically include increased energy cost of walking,<xref rid="r2" ref-type="bibr"><sup>2</sup></xref><sup>, </sup><xref rid="r3" ref-type="bibr"><sup>3</sup></xref> reduced walking speed,<xref rid="r3" ref-type="bibr"><sup>3</sup></xref><sup>, </sup><xref rid="r4" ref-type="bibr"><sup>4</sup></xref> pain,<xref rid="r5" ref-type="bibr"><sup>5</sup></xref> impaired balance,<xref rid="r6" ref-type="bibr"><sup>6</sup></xref><sup>, </sup><xref rid="r7" ref-type="bibr"><sup>7</sup></xref> and (fear of) falling,<xref rid="r8" ref-type="bibr"><sup>8</sup></xref><sup>, </sup><xref rid="r9" ref-type="bibr"><sup>9</sup></xref> which limit the performance of daily physical activities,<xref rid="r10" ref-type="bibr"><sup>10</sup></xref> and negatively impact quality of life.<xref rid="r5" ref-type="bibr"><sup>5</sup></xref><sup>, </sup><xref rid="r11" ref-type="bibr"><sup>11</sup></xref></p><p>Lower limb orthoses, <italic toggle="yes">i.e.</italic> ankle-foot orthoses (AFOs) and knee-ankle-foot orthoses (KAFOs), are commonly applied to improve walking in NMD.<xref rid="r12" ref-type="bibr"><sup>12</sup></xref><sup>, </sup><xref rid="r13" ref-type="bibr"><sup>13</sup></xref> A variety of orthoses are provided, which differ with respect to their orthotic properties, such as their type, material, stiffness and weight.<xref rid="r14" ref-type="bibr"><sup>14</sup></xref><sup>, </sup><xref rid="r15" ref-type="bibr"><sup>15</sup></xref> Overall, evidence for the effectiveness of lower limb orthoses to improve walking in adults with NMD has low certainty,<xref rid="r16" ref-type="bibr"><sup>16</sup></xref><sup>, </sup><xref rid="r17" ref-type="bibr"><sup>17</sup></xref> and evidence comparing the effects of various types of lower limb orthoses is scarce. This inadequately supports clinical decision-making with respect to matching the orthosis to the individual. Hence, choices on the orthosis design are largely made according to preferences and experiences of the prescribing physician and/or orthotic technician, leading to inconsistent orthotic practices. Consequently, a substantial group of people with NMD is provided with suboptimal orthoses that do not, or only partially improve biomechanical gait parameters and functional walking outcomes.<xref rid="r18" ref-type="bibr"><sup>18</sup></xref></p><p>In 2012, a multidisciplinary guideline for the prescription of lower limb orthoses in NMD was developed to enhance standardization of care,<xref rid="r19" ref-type="bibr"><sup>19</sup></xref> which was authorized for use in clinical practice. However, the guideline is currently not widely used, which may be due to limited availability of required resources and limited expertise. In a recent cohort study with a retrospective analysis of clinical care data, the application of the guideline in a multidisciplinary expert setting (<italic toggle="yes">i.e.</italic> specialized orthotic care) improved personal goal attainment and perceived walking ability compared to usual care in adults with NMD, including mostly polio survivors.<xref rid="r20" ref-type="bibr"><sup>20</sup></xref> To allow for an unbiased comparison, and to strengthen evidence for a diverse NMD population, outcomes should be collected prospectively for both specialized orthotic care and usual orthotic care in a randomized design. Further, a comparison of costs and cost-effectiveness of specialized compared to usual orthotic care is required for policy makers to assess its affordability and accessibility for individuals with NMD. While specialized care is expected to come at higher healthcare costs, its anticipated superior effectiveness could justify these costs and lead to cost-effectiveness.</p><p>The aim of this study was to evaluate the effectiveness and cost-effectiveness of specialized orthotic care on improving functioning in adults with NMD compared to usual orthotic care. We hypothesized that specialized orthotic care would be more effective in attaining personal goals and reducing energy cost of walking compared to usual orthotic care. Secondarily, we hypothesized that specialized orthotic care would be cost-effective from a societal and healthcare perspective, given the anticipated benefits on functioning.</p><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Study design</title><p>We conducted an open-label blinded end-point randomized controlled trial (RCT) with an economic evaluation alongside. The study was approved by the Medical Ethics Committee of Amsterdam UMC, location Academic Medical Center (AMC), the Netherlands. The trial was prospectively registered at the WHO International Clinical Trial Register Platform (NL7511), and the protocol has been previously published.<xref rid="r21" ref-type="bibr"><sup>21</sup></xref> The trial reporting followed the guidelines of the Consolidated Standards of Reporting Trials (CONSORT),<xref rid="r22" ref-type="bibr"><sup>22</sup></xref> Statistical Analyses and Methods in the Published Literature (SAMPL),<xref rid="r23" ref-type="bibr"><sup>23</sup></xref> and Consolidated Health Economic Evaluation Reporting Standards (CHEERS).<xref rid="r24" ref-type="bibr"><sup>24</sup></xref></p></sec><sec><title>Study population</title><p>From May 2019 to February 2022, adults with NMD were recruited from 22 hospitals and rehabilitation centers throughout the Netherlands, and through the Dutch patients association for Neuromuscular Diseases (Spierziekten Nederland, in Dutch). We defined NMD as neuromuscular diseases, hereditary or acquired, such as Charcot-Marie-Tooth disease or poliomyelitis, and other disorders affecting the peripheral part of the neuromuscular system, causing flaccid, non-spastic, muscle weakness, which was checked by a rehabilitation physician. A range of NMDs was considered eligible as orthotic treatment aims to improve walking by addressing muscle weakness, a common impairment across conditions, rather than targeting the specific underlying pathophysiology. Inclusion and exclusion criteria are shown in <xref rid="tI" ref-type="table">Table I</xref>. All participants provided written informed consent before taking part.</p><table-wrap position="float" id="tI" orientation="portrait"><label>Table I</label><caption><title><italic toggle="yes">&#8212;</italic>Inclusion and exclusion criteria.</title></caption><table frame="hsides" rules="groups"><col width="57%" span="1"/><col width="43%" span="1"/><thead><tr><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inclusion criteria</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Exclusion criteria</th></tr></thead><tbody><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">1. age &#8805;18 years;<break/>2. presence of plantarflexor muscle weakness (<italic toggle="yes">i.e</italic>. Medical Research Council (MRC) scale score &lt;5 or inability to perform a single leg heel-rise &gt;3 times) and/or quadriceps muscle weakness (<italic toggle="yes">i.e</italic>. MRC score &lt;5);<break/>3. experiencing walking problems such as increased walking effort, pain, impaired balance and/or falls during standing and/or walking;<break/>4. ability to walk for 6 minutes continuously at comfortable speed with or without assistive device (<italic toggle="yes">e.g</italic>. cane, walker);<break/>5. motivated to use an orthosis.</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1. not indicated for a (new) lower limb orthosis based upon physical examination and 3D gait analysis;<break/>2. insufficient mastery of the Dutch language.</td></tr></tbody></table></table-wrap></sec><sec><title>Randomization and allocation concealment</title><p>After a screening, conducted by a rehabilitation medicine specialist, eligible participants were randomized (1:1 ratio) to specialized orthotic care (intervention) or usual orthotic care (control), stratified by disease severity, <italic toggle="yes">i.e</italic>. distal leg muscle weakness <italic toggle="yes">versus</italic> (distal and) proximal leg muscle weakness. Randomization was performed with a computer-generated scheme (Castor EDC, Amsterdam, the Netherlands), with blocks of random sequences with variable sizes (2, 4, 6). Measurements were performed by a blinded assessor, and participants were instructed not to reveal their allocation at each assessment.</p></sec><sec><title>Intervention</title><p>The intervention group received specialized orthotic care from a multidisciplinary team consisting of a rehabilitation physician, orthotic technician, physiotherapist, gait analyst and sometimes a shoe technician according to the guideline for lower limb orthoses in NMD<xref rid="r19" ref-type="bibr"><sup>19</sup></xref> in an expert setting. The guideline aligns with the &#8216;Process description medical devices,&#8217;<xref rid="r25" ref-type="bibr"><sup>25</sup></xref> encompassing a series of treatment steps for which standardized protocols were developed: problem reporting; identifying the care need; creating the care plan; selecting, trying and deciding on the orthosis; orthosis delivery and instruction; using the orthosis; and evaluation (Supplementary Digital Material 1: Supplementary Table I). As standard part of the diagnostic and assessment process, all participants in the intervention group underwent a 3D gait analysis. The control group received usual orthotic care at their regular care center initiated by their rehabilitation physician, and included provision of orthopedic shoes, AFOs, or KAFOs, according to the policy of the center. To reflect routine clinical practice, no standardized training or protocol was implemented across the usual care centers.</p></sec><sec><title>Outcome measures</title><p>At baseline (T1), demographics and clinical characteristics were assessed, including self-reported walking distance, and for the left and right leg: 1) muscle strength of the hip flexors, extensors, abductors and adductors, knee flexors and extensors, plantarflexors and dorsiflexors, manually assessed according to the MRC scale;<xref rid="r26" ref-type="bibr"><sup>26</sup></xref> 2) passive joint range of motion; 3) bony and joint deformities; and 4) sensory impairments.</p><p>Primary and secondary outcomes were assessed with the orthotic device that was used in daily life (at baseline; T1), and with the newly provided orthosis (at 12 and 24 weeks after delivery of the orthosis; T2 and T3), and entered into a Castor database. If the newly provided orthoses were not used, measurements were performed with the orthosis or footwear that was being used at that moment. Orthotic properties (<italic toggle="yes">e.g</italic>. type, weight, material) were documented at each measurement. Adverse events likely to be related to using the orthosis (<italic toggle="yes">i.e</italic>. pressure sores, falls, pain, and muscle soreness) were documented when reported.</p><sec><title>Primary outcomes</title><p>Personal goal attainment was evaluated at 24 weeks follow-up with the Goal Attainment Scale (GAS).<xref rid="r27" ref-type="bibr"><sup>27</sup></xref><sup>, </sup><xref rid="r28" ref-type="bibr"><sup>28</sup></xref> At baseline, a maximum of two goals were formulated by a blinded researcher based on what the participant wished to achieve in daily life in terms of activities and participation according to the International Classification of Functioning, Disability and Health (ICF) framework.<xref rid="r29" ref-type="bibr"><sup>29</sup></xref> Subsequently, goals were scaled by creating six GAS outcome levels, ranging from -3 to +2 (where the current situation was defined as -2 and the desired attainment goal as 0). Attainment of the goals at T2 and T3 was scored as -3 for worsened, -2 for unchanged, -1 for somewhat less than expected, 0 for expected outcome, +1 for somewhat more than expected, and +2 for much more than expected by the same blinded researcher. As for some participants only one goal was formulated, we determined the participants&#8217; first set GAS goals as primary for the analysis. An improvement of &#8805;2 GAS points is regarded clinically relevant.<xref rid="r28" ref-type="bibr"><sup>28</sup></xref></p><p>The change in energy cost of walking from baseline to 24 weeks follow-up was assessed during 6-minute walk tests (6MWT) at self-selected comfortable speed on an indoor 34-meter oval track. Respiratory gases were measured breath-by-breath with a portable gas-analysis system (Cosmed K5, Rome, Italy), allowing continuous measurement of oxygen uptake (VO<sub>2</sub>) and respiratory exchange ratio (RER). For analysis, we visually identified a steady-state period of &#8805;1 minute during the last three minutes of the 6MWT. Finally, gross energy cost of walking in J/kg/m was calculated for this period with the following formula: [(4.940*RER)+16.040]*VO<sub>2</sub>/speed.<xref rid="r30" ref-type="bibr"><sup>30</sup></xref> A reduction of &#8805;0.55 J/kg/m is considered clinically relevant.<xref rid="r3" ref-type="bibr"><sup>3</sup></xref></p></sec><sec><title>Secondary outcomes</title><p>Secondary outcomes included comfortable walking speed (during the 6MWT), spatiotemporal parameters and gait biomechanics (ankle and knee kinematics and kinetics during the stance phase of gait, as lower limb orthoses are applied to impact gait on these aspects), perceived stability and pain during walking, perceived physical functioning,<xref rid="r31" ref-type="bibr"><sup>31</sup></xref> frequency of falls, fear of falling,<xref rid="r32" ref-type="bibr"><sup>32</sup></xref> perceived fatigue,<xref rid="r33" ref-type="bibr"><sup>33</sup></xref> satisfaction with the orthosis and provided services,<xref rid="r34" ref-type="bibr"><sup>34</sup></xref> and adherence to wearing the orthosis. More details are available elsewhere.<xref rid="r21" ref-type="bibr"><sup>21</sup></xref></p></sec></sec><sec><title>Economic evaluation</title><p>The economic evaluation was performed from a societal and healthcare perspective. Data on resource use was collected with cost questionnaires at T1, directly post-delivery of the orthosis, and at T2 and T3. The following costs were included: intervention costs (directly related to orthotic treatment), other healthcare costs (<italic toggle="yes">i.e</italic>. primary and secondary healthcare costs, medication, and home care), costs related to unpaid productivity, absenteeism and presenteeism, and informal care costs. From the societal perspective, all costs were included, whereas only those accruing to the formal Dutch healthcare perspective were included for the healthcare perspective. All cost categories were valued according to the Dutch manual for costing studies in health care.<xref rid="r35" ref-type="bibr"><sup>35</sup></xref> For absenteeism, this meant that the Friction Cost Approach was used, where productivity losses are truncated at the duration employers need to replace sick workers.<xref rid="r35" ref-type="bibr"><sup>35</sup></xref></p><p>Outcome measures used for the economic evaluation were Quality Adjusted Life Years (QALYs), and the two primary outcomes, being personal goal attainment and change in energy cost of walking. Please note that a cost-effectiveness analysis for QALYs is equivalent to a cost-utility analysis. QALYs were based on the EuroQoL 5-Dimensions 5-Levels (EQ-5D-5L) questionnaire,<xref rid="r36" ref-type="bibr"><sup>36</sup></xref> administered at T1, delivery of the orthosis, T2 and T3. The patients&#8217; EQ-5D-5L health states were converted into utility scores using the Dutch tariff.<xref rid="r37" ref-type="bibr"><sup>37</sup></xref> Subsequently, QALYs were estimated by multiplying the patients&#8217; utility scores by the time spent in a certain health state.</p></sec><sec><title>Sample size</title><p>The sample size for this study was calculated using a power analysis of expected differences in primary outcomes between specialized and usual orthotic care. From earlier studies,<xref rid="r18" ref-type="bibr"><sup>18</sup></xref><sup>, </sup><xref rid="r38" ref-type="bibr"><sup>38</sup></xref> the anticipated difference in energy cost of walking reduction between groups was 0.60 J/kg/m. Based on an alpha of 0.05, power of 80%, estimated correlation coefficient of the repeated measures of 0.76 and a SD of 0.90 J/kg/m, 30 patients per treatment group were necessary. Allowing for a 15% drop-out, 70 participants were required. This sample size also allowed detection of 1-point difference in GAS scores between groups.</p></sec><sec><title>Statistical analysis</title><p>Baseline characteristics of participants were summarized with descriptive statistics. Primary and secondary outcomes were assessed as change from baseline to 24 weeks follow-up. Analyses of continuous, normally distributed outcomes were conducted with linear mixed models with time as within-subject factor (T1, T2, and T3) and group as between-subject factor (intervention and control), adjusted for stratification. Differences in GAS scores between groups at T3 were tested with non-parametric Mann-Whitney Wilcoxon Tests. Other not normally distributed outcome measures were analyzed congruently. Analyses were based on the intention-to-treat (ITT) population, defined as all included participants. In addition, secondary per-protocol (PP) analyses were performed, in which participants were excluded if they did not receive orthotic treatment for any reason, or if they did not use the newly provided orthosis. Statistical significance was set at P&lt;0.05. For the primary outcome measures, we employed a Bonferroni correction, and adjusted the significance level to P&lt;0.025 to address the issue of multiple testing. Full details are provided in the statistical analysis plan (Supplementary Digital Material 2: Supplementary Text File 1).</p><p>Economic evaluation analyses were performed according to Ben <italic toggle="yes">et al.</italic><xref rid="r39" ref-type="bibr"><sup>39</sup></xref> That is, missing data were imputed using &#8220;Multivariate Imputation by Chained Equations&#8221;. Ten datasets were imputed in order for the loss of efficiency to be &lt;5%. The imputation model included all available cost and effect values, age, gender, duration of delivery process, and work status. Imputed datasets were analyzed, after which pooled estimates were calculated using Rubin&#8217;s rules.<xref rid="r40" ref-type="bibr"><sup>40</sup></xref> Mean differences in total costs and effects between groups were estimated using seemingly unrelated regression analyses, corrected for baseline values, if available, and the delivery process duration. To account for the skewed nature of cost data, 95% confidence intervals surrounding cost differences were estimated using Bias Corrected and Accelerated bootstrapping with 5000 replication. Subsequently, incremental cost-effectiveness ratios were calculated as the mean cost differences divided by the mean effect differences. The probability of specialized orthotic care being cost-effective compared to usual orthotic care was plotted for a range of willingness-to-pay values in cost-effectiveness acceptability curves (CEACs). Sensitivity analyses were performed from the societal perspective; 1) unadjusted for the orthotic care process duration; 2) adjusted for work status; 3) using the Human Capital Approach instead of the Friction Cost Approach for valuing absenteeism costs, in which all productivity losses are considered, irrespective of whether the sick worker is replaced.</p><p>The analyses on effectiveness were performed with SPSS (V25; IBM SPSS, Chicago, Illinois, USA), and cost-effectiveness with R studio.</p></sec><sec sec-type="data-availability"><title>Data availability</title><p>The data associated with the paper are not publicly available but are available from the corresponding author on reasonable request.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Participant flow</title><p>Between May 2019 and August 2022, 71 individuals were screened for eligibility. Sixty-one were enrolled: 21 females (34%), mean age 62&#177;12 and randomized to specialized orthotic care (N.=31) or usual orthotic care (N.=30). One participant in the specialized orthotic care group was erroneously randomized while not meeting all inclusion criteria, and therefore excluded after inclusion. Hence, the ITT sample consisted of 60 participants (30 in specialized; 30 in usual orthotic care) (<xref rid="f1" ref-type="fig">Figure 1</xref>). Baseline participant characteristics, and types of orthoses used at follow-up are shown in <xref rid="tII" ref-type="table">Table II</xref>. The PP sample consisted of 51 participants (24 in specialized; 27 in usual orthotic care). The mean (SD) time between the baseline and last follow-up measurement was 11.7 (3.9) months. The last measurement was conducted in February 2023.</p><fig position="float" id="f1" fig-type="figure" orientation="portrait"><label>Figure 1</label><caption><p>&#8212;Study flow chart.</p></caption><graphic position="float" orientation="portrait" xlink:href="8770-f1.jpg"/></fig><table-wrap position="float" id="tII" orientation="portrait"><label>Table II</label><caption><title><italic toggle="yes">&#8212;</italic>Baseline participant demographics and clinical characteristics, and types of orthoses used at the follow-up measurements and their orthotic properties.</title></caption><table frame="hsides" rules="groups"><col width="54.55%" span="1"/><col width="22.73%" span="1"/><col width="22.72%" span="1"/><thead><tr><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Parameters</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Intervention group<break/>(N.=30)</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Control group<break/>(N.=30)</th></tr></thead><tbody><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">
<italic toggle="yes">Demographics</italic>
</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">64&#177;11</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">59&#177;14</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Gender (female)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">9 (30%)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">11 (37%)</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">
<italic toggle="yes">Clinical characteristics</italic>
</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Diagnosis</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Charcot-Marie-Tooth</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">8</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">10</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Chronic idiopathic axonal polyneuropathy</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">12</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Poliomyelitis</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Myotonic dystrophy</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Peripheral nerve injury</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Chronic inflammatory demyelinating polyneuropathy</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Facioscapulohumeral muscular dystrophy</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Inclusion body myositis</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Guillain-Barr&#233; Syndrome</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Spina bifida</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Spinal muscular atrophy</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Other</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Unilateral / bilateral affected</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3/27</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5/25</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Distal / (distal +) proximal muscle weakness</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">18/12</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">17/13</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Muscle strength (MRC scores), most/least affected side</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Plantar flexors (range 1-5)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4 [0; 4]/4 [3; 5]</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4 [2; 4]/5 [4; 5]</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Dorsiflexors (range 1-5)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3 [0; 4]/4 [1; 5]</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3 [1; 4]/3 [2; 5]</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Knee extensors (range 1-5)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5 [5; 5]/5 [5; 5]</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5 [5; 5]/5 [5; 5]</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Sum score leg <sup>a</sup> (range 1-40)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">35 [30; 37]/37 [33; 38]</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">35 [31; 38]/37 [34; 40]</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Presence / absence of sensory impairments</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">22/8</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">15/14<sup>b</sup></td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Presence / absence of joint deformities and/or malalignments</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">At knee level</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5/25</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3/27</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">At ankle/hindfoot level</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">11/19</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">11/19</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">At midfoot level</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">14/16</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">11/19</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">At forefoot level</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0/30</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1/29</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">At level of the toes</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">7/23</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">7/23</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Self-reported walking distance</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Only in/around house</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4 (13%)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2 (7%)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Less than 1 kilometer</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">14 (47%)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">17 (57%)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">More than 1 kilometer</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">12 (40%)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">11 (37%)</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Use of orthosis at time of inclusion</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">None/orthopedic shoes/AFO/KAFO</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">6/9/15/0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">11/2/16/1</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">
<italic toggle="yes">Types of orthoses used at the follow-up measurements and their orthotic properties</italic>
</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Orthotic type</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">(High) orthopedic shoes</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Rigid AFO(s)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Dorsal/ventral leaf AFO(s)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">20</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">13</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Hinged AFO(s)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">8</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">SC-KAFO</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Locked KAFO</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Fabrication AFO/KAFO</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Prefabricated</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">10</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Custom-made</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">21</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">14</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Custom-made shoes</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Material AFO/KAFO</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Carbon-composite</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">26</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">23</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Polypropylene</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Custom-made shoes</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Weight (kg)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.54&#177;0.23</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.55&#177;0.37</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Orthotic type <italic toggle="yes">versus</italic> orthosis used at baseline</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">First orthosis</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">6</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">10</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">New type</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">18</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">9</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Same/repeated type</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">9</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Use of orthotic device at T2</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Always</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 6, Outside: 13</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 7, Outside: 17</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Mostly</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 6, Outside: 10</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 4, Outside: 7</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Rarely</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 10, Outside: 3</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 13, Outside: 2</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Never</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 4, Outside: 0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 3, Outside: 1</td></tr><tr><td colspan="3" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Use of orthotic device at T3</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Always</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 6, Outside: 15</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 4, Outside: 18</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Mostly</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 11, Outside: 8</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 8, Outside: 8</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Rarely</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 8, Outside: 2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 1, Outside: 2</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Never</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 2, Outside: 2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Inside: 5, Outside: 0</td></tr></tbody></table><table-wrap-foot><p>Data are presented as mean&#177;SD, unless reported otherwise.
AFO: ankle-foot orthosis; KAFO: knee-ankle-foot orthosis; MRC: Medical Research Council; SC-KAFO: stance-control knee-ankle-foot orthosis; T2: measurement at 12 weeks follow-up; T3: measurement at 24 weeks follow-up.
<sup>a</sup> Sum of the MRC scores of hip flexors, extensors, abductors and adductors, knee flexors and extensors, ankle plantar flexors, and dorsal flexors; <sup>b</sup> occurrence of sensory impairments was not assessed in one participant.</p></table-wrap-foot></table-wrap></sec><sec><title>Implementation of interventions</title><sec><title>Specialized orthotic care</title><p>Nineteen participants received specialized orthotic care at Amsterdam UMC and nine at Klimmendaal. The following orthosis types were provided (unilateral or bilateral): ventral or dorsal leaf spring AFO(s) (N.=18), (spring-) hinged AFO(s) (N.=9), and a stance-control KAFO (N.=1), of which 25 were custom-made and three were prefabricated (Supplementary Digital Material 3: Supplementary Table II). Fourteen participants were additionally provided with (semi-) custom-made orthopedic shoes. For 11 participants who received dorsal leaf spring AFOs. An additional 3D gait analysis was performed for 11 participants, to determine the stiffness of the dorsal leaf spring AFO(s) according to Waterval <italic toggle="yes">et al.</italic><xref rid="r41" ref-type="bibr"><sup>41</sup></xref> Four participants could not get used to their newly provided orthosis (all hinged or spring-hinged AFOs), and were provided with a new orthosis during the study. The mean duration between baseline and orthosis delivery was 7.3&#177;2.7 months.</p></sec><sec><title>Usual orthotic care</title><p>The control group received usual orthotic care in 15 different centers. The following orthosis types were provided: (high) orthopedic shoes (N.=4), solid AFO(s) (N.=1), ventral or dorsal leaf spring AFO(s) (N.=13), (spring-) hinged AFO(s) (N.=8), and locked KAFOs (N.=2), of which 18 were custom-made and 10 were prefabricated (Supplementary Table II). Four participants were additionally provided with (semi-) custom-made orthopedic shoes. One participant was not provided with an orthosis, but the rehabilitation physician prescribed a walker instead. One participant did not use the newly provided orthopedic shoes. The mean duration between baseline and orthosis delivery was 5.0&#177;3.5 months.</p></sec></sec><sec><title>Primary outcomes</title><p>For all participants, at least one GAS goal was formulated, except for one participant who did not have evident goals beyond the current situation. In the control group, three goals could not be evaluated, because the daily activities or the use of assistive devices had changed, which determined the setting of the goals. Goals were set on reducing falls (22%), reducing fatigue during walking (15%), improving standing (8%), minimizing reliance on walking aids (7%), alleviating pain (5%), reducing overall fatigue (3%), and improving usability (3%). The ITT-analysis showed that the specialized orthotic care group had a significantly higher first set GAS score compared to the usual orthotic care group at 24 weeks follow-up (median [IQR] score: 0 [-1 to 1] <italic toggle="yes">versus</italic> -1 [-2.75 to 1], P=0.011, <xref rid="f2" ref-type="fig">Figure 2</xref>). PP-analyses also showed a similar significant effect (P=0.006).</p><fig position="float" id="f2" fig-type="figure" orientation="portrait"><label>Figure 2</label><caption><p>&#8212;Effects of specialized orthotic care (in blue) and usual orthotic care (in grey) on the primary outcomes, depicted for each measurement point (T1, T2, and T3). A: Scores on the attainment of participants&#8217; first formulated personal goal, evaluated with the Goal Attainment Scale (GAS), note that all participants scored &#8216;-2&#8217; at T1, since this score represents the starting point. B: Mean energy cost of walking (in J/kg/m), error bars represent standard deviations. *Significant difference, P&lt;0.05.</p></caption><graphic position="float" orientation="portrait" xlink:href="8770-f2.jpg"/></fig><p>Data on energy cost of walking was missing for one participant who did not tolerate the face mask due to anxiety. Further, T2 data of three participants could not be collected due to COVID-19 restrictions, and T2 and/or T3 data of two other participants were excluded from the analyses as different walking aids were used during the 6MWT between measurements. The ITT-analysis showed a mean difference in walking energy cost reduction between groups of 0.473 J/kg/m (95% CI: -1.105 to 0.159), which was not significant (P=0.140). In the specialized orthotic care group, energy cost decreased significantly with 11.8% (-0.55 J/kg/m; 95% CI: -0.99 to -0.11) from baseline to 24 weeks follow-up, but did not change following usual orthotic care (-0.08 J/kg/m; 95% CI: -0.32 to 0.26), <xref rid="f2" ref-type="fig">Figure 2</xref>. PP-analyses also showed no difference in walking energy cost reduction between groups (&#946;=-0.455 J/kg/m, 95% CI: -1.134 to 0.225 P=0.186).</p><p>With respect to the secondary outcomes (<xref rid="tIII" ref-type="table">Table III</xref>), change in walking speed during the 6MWT did not differ significantly between groups (specialized: +0.11 m/s, 95% CI: 0.06 to 0.16; usual: +0.06 J/kg/m, 95% CI: 0.01 to 0.11, &#946;=0.054 m/s, 95% CI: -0.019-0.127, P=0.144). </p><table-wrap position="float" id="tIII" orientation="portrait"><label>Table III</label><caption><title><italic toggle="yes">&#8212;</italic>Effects of specialized orthotic care compared to usual orthotic care on energy cost of walking and secondary outcome measures over time.</title></caption><table frame="hsides" rules="groups"><col width="17.5%" span="1"/><col width="10.28%" span="1"/><col width="10.28%" span="1"/><col width="10.28%" span="1"/><col width="10.28%" span="1"/><col width="10.28%" span="1"/><col width="10.28%" span="1"/><col width="13.41%" span="1"/><col width="7.41%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" colspan="1">Parameter</th><th colspan="3" valign="top" align="left" scope="colgroup" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1">Specialized orthotic care</th><th colspan="3" valign="top" align="left" scope="colgroup" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1">Usual orthotic care</th><th colspan="2" valign="top" align="left" scope="colgroup" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1">Difference in change over time (T3-T1) between groups</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1">T1</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">T2</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">T3</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">T1</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">T2</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">T3</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Beta (95% CI) from LMM</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">
<italic toggle="yes">Walking effort outcomes</italic>
</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=30</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=27</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=27</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=29</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=26</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=28</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Gross energy cost of walking (J/kg/m)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5.37&#177;2.36</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5.03&#177;2.38</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4.86&#177;2.56</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4.72&#177;0.90</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4.76&#177;1.15</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4.69&#177;1.13</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.473 <break/>(-1.105, 0.159)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.140</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Walked distance (m)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">328.4&#177;95.8</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">372.4&#177;104.7</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">369.6&#177;102.0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">348.6&#177;76.4</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">366.5&#177;83.1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">373.9&#177;80.4</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">11.78 <break/>(-12.51; 36.08)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.337</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Walking speed (m/s)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.91&#177;0.27</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.03&#177;0.29</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.04&#177;0.29</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.98&#177;0.20</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.01&#177;0.25</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.04&#177;0.23</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.054<break/> (-0.019, 0.127)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.144</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Perceived intensity (Borg, range 0 to 10)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4.6&#177;2.6</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4.5&#177;2.2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4.3&#177;2.3</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5.2&#177;1.9</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4.6&#177;2.2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5.2&#177;2.0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.416 <break/>(-1.395, 0.563)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.402</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">
<italic toggle="yes">Spatiotemporal parameters</italic>
</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=26</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=24</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=24</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=29</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=26</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=27</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Walking speed (m/s)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.98&#177;0.29</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.12&#177;0.26</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.14&#177;0.25</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.98&#177;0.21</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.03&#177;0.30</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.04&#177;0.027</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.075 <break/>(0.003, 0.147)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.042*</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Heel-off timing (%GC)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">53.6&#177;4.8</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">48.4&#177;4.7</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">48.6&#177;5.4</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">53.6&#177;3.0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">51.1&#177;4.2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">50.3&#177;5.7</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-1.791 <break/>(-4.562, 0.979)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.201</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Step length (m)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.60&#177;0.13</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.66&#177;0.11</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.67&#177;0.10</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.59&#177;0.09</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.60&#177;0.13</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.62&#177;0.11</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.040 <break/>(0.004, 0.076)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.031*</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">CoP progression at Mst (cm)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2.0&#177;3.1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4.5&#177;2.7</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.6&#177;2.6</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.4&#177;2.3</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2.3&#177;1.7</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2.4&#177;2.2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">7.416 <break/>(-3.922, 18.754)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.196</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">
<italic toggle="yes">Gait biomechanics</italic>
</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=26</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=24</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=24</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=29</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=26</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=27</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/></tr><tr><td colspan="9" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Ankle</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Max angle Tst (&#176;)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">17.2&#177;6.7</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">17.1&#177;4.2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">15.8&#177;4.9</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">17.0&#177;5.1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">16.9&#177;5.0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">16.8&#177;5.3</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-1.177 <break/>(-3.692, 1.338)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.353</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Max moment Tst/Psw (Nm)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.92&#177;0.35</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.05&#177;0.23</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.05&#177;0.24</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.90&#177;0.29</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.98&#177;0.28</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.94&#177;0.28</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.060 <break/>(-0.034, 0.154)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.209</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Max power Tst (W/kg)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.41&#177;0.99</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.26&#177;0.76</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.29&#177;0.68</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.42&#177;0.77</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.27&#177;0.68</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.30&#177;0.79</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.027 <break/>(-0.289, 0.234)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.835</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Timing max power (%GC)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">60.0&#177;2.5</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">58.4&#177;2.3</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">58.6&#177;2.0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">59.4&#177;2.7</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">58.7&#177;2.2</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">58.6&#177;2.8</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.685 <break/>(-1.683, 0.314)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.177</td></tr><tr><td colspan="9" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Knee</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Max angle stance phase (&#176;)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">22.9&#177;7.0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">23.2&#177;6.8</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">23.0&#177;6.5</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">18.4&#177;12.4</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">19.0&#177;11.7</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">19.2&#177;11.6</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.062 <break/>(-2.419, 4.543)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.545</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Min angle Mst (&#176;)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">11.9&#177;5.9</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">12.3&#177;6.0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">10.6&#177;5.5</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">8.2&#177;10.7</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">8.4&#177;10.1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">8.5&#177;9.9</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.449 <break/>(-3.594, 2.697)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.778</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Max moment Mst (Nm)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.62&#177;0.31</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.70&#177;0.34</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.74&#177;0.25</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.47&#177;0.46</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.52&#177;0.46</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.57&#177;0.46</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.037 <break/>(-0.099, 0.173)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.592</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Min moment Tst (Nm)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.11&#177;0.28</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.08&#177;0.26</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.13&#177;0.21</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.13&#177;0.29</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.14&#177;0.29</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.11&#177;0.28</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.31 <break/>(-0.140, 0.077)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.569</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">
<italic toggle="yes">Perceived functioning outcomes</italic>
</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=30</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=28<sup>a</sup></td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=28</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=30</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=28</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N.=28</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Physical functioning (SF36-PF, range 0-100)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">48.00&#177;20.49</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">55.19&#177;22.60</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">55.36&#177;22.69</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">46.33&#177;17.90</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">47.68&#177;21.75</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">45.36&#177;19.81</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">7.511 <break/>(0.324, 14.699)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.041*</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Stability during walking (NRS, range 0-10)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4.2&#177;2.0</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">6.2&#177;2.1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">6.2&#177;1.9</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">4.7&#177;2.1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5.5&#177;2.1</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5.8&#177;1.9</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.468 <break/>(-0.534, 1.470)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.354</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Pain during walking (NRS, range 0-10)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2.4&#177;2.3</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.9&#177;1.9</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.9&#177;1.8</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2.7&#177;2.5</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2.8&#177;2.5</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2.5&#177;2.7</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.336 <break/>(-1.219, 0.548)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.449</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Fatigue (FSS, range 9-63)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">39.10&#177;11.06</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">34.58&#177;12.00</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">35.75&#177;13.22</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">40.77&#177;11.93</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">39.04&#177;14.08</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">40.39&#177;13.77</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-1.866 <break/>(-6.746, 3.013)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.447</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Fear of falling (FES-I, range 7-28)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">13.63&#177;3.56</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">12.33&#177;3.35</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">12.68&#177;3.55</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">13.73&#177;3.89</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">13.79&#177;4.09</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">13.61&#177;4.72</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.464 <break/>(-2.005, 1.077)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.548</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Reported falls (last 3 months)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1 [0-2]</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1 [0-2]</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.5 [0-2]</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.5 [0-3]</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1 [0-1]</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1 [0-2]</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.134 <sup>b</sup></td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">
<italic toggle="yes">Satisfaction with the orthosis (D-QUEST)<sup>c</sup></italic>
</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=21</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=27</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=28</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=20</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=26</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">N=27</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Satisfaction overall (range 0-5)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.47&#177;0.54</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.91&#177;0.59</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.97&#177;0.58</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.46&#177;0.47</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.69&#177;0.67</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.61&#177;0.78</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.025 <sup>d</sup> *</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Orthosis-specific items (range 0-5)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.42&#177;0.54</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.93&#177;0.58</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.99&#177;0.57</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.38&#177;0.48</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.69&#177;0.76</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.63&#177;0.81</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.030 <sup>d</sup> *</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Service-specific items (range 0-5)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.56&#177;0.80</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.88&#177;0.75</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.92&#177;0.80</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.62&#177;0.69</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.63&#177;0.84</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3.54&#177;0.89</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.050 <sup>d</sup></td></tr></tbody></table><table-wrap-foot><p>LMM: linear mixed models; 6MWT: 6-minute walk test, NRS: Numeric Rating Scale, SF36-PF: the physical functioning domain of the Short Form-36 questionnaire, FSS: Fatigue Severity Scale, FES: Falls Efficacy Scale, D-QUEST: Dutch version of the Quebec User Evaluation of Satisfaction with assistive Technology.
Outcomes presented as mean&#177;SD or median [interquartile range]. For all questionnaires, except for the FSS and FES-I, a higher score represents better functioning. Statistical significance was set at a P value &lt;0.025 for primary outcome measures, and a P value &lt;0.025 for secondary outcome measures. Green highlighted variables indicate significant effects in favor of intervention group.
<sup>a</sup> Data on fatigue were missing for one participant; <sup>b</sup> differences in &#916; falls between groups were tested with Mann-Whitney Wilcoxon test, as data was not normally distributed; <sup>c</sup> D-QUEST was only taken at T1 when participants already used a lower limb orthosis or orthopedic shoes; <sup>d</sup> differences in scores at T3 between groups were tested with <italic toggle="yes">t</italic>-tests, as D- QUEST data at T1 was only available for a subgroup.</p></table-wrap-foot></table-wrap><p>As regards to the 3D gait analysis, the specialized orthotic care group showed a greater increase in walking speed compared to usual orthotic care (specialized: +0.13 m/s, 95% CI: 0.08 to 0.18; usual: +0.06 m/s, 95% CI: 0.01 to 0.11 respectively, P=0.042), and a greater increase in step length (specialized: +0.06 m, 95% CI: 0.04 to 0.09; usual: +0.02 m, 95% CI: -0.00 to 0.05, P=0.031). No differences between groups were found for other gait parameters (P&gt;0.177). Perceived physical functioning improved more in the specialized compared to the usual orthotic care group (&#946;=7.511, 95% CI: 0.32 to 0.14.67, P=0.041). No between-group effects were found for perceived stability and pain during walking, fatigue, fear of falling, and number of reported falls (P&gt;0.134). Specialized orthotic care led to a greater overall satisfaction with the orthosis and provided services compared to usual orthotic care, (3.97&#177;0.58 <italic toggle="yes">versus</italic> 3.61&#177;0.78, P=0.025), and to a greater satisfaction with items related to the orthosis specifically (3.99&#177;0.57 <italic toggle="yes">versus</italic> 3.63&#177;0.81, P=0.030).</p></sec><sec><title>Adverse events</title><p>Two serious adverse events associated with a diagnosis of cancer were reported in the intervention group, of which one resulted in death before start of treatment. The other occurred during follow-up and necessitated rescheduling of the T3 measurement. Significantly more participants reported adverse events in the control group compared to the intervention group (14 <italic toggle="yes">versus</italic> 4, P=0.01). Four participants in the intervention group reported the following events: pressure sores (N.=2), fall from stairs (N.=1), and spinal stenosis (N.=1). In the control group, 17 adverse events involving 14 participants were reported; pressure sores (N.=10), ankle/leg edema (N.=2), knee pain (N.=1), suspected hernia (N.=1), and falls from stairs (N.=2).</p></sec><sec><title>Cost-effectiveness</title><p>From the societal perspective, specialized orthotic care dominated usual orthotic care for QALYs, personal goal attainment and energy cost of walking, meaning that specialized orthotic care was on average less costly and more effective (<xref rid="tIV" ref-type="table">Table IV, V</xref><xref rid="tV" ref-type="table"/>). </p><table-wrap position="float" id="tIV" orientation="portrait"><label>Table IV</label><caption><title><italic toggle="yes">&#8212;</italic>Summary of costs per cost category and cost-effectiveness results.</title></caption><table frame="hsides" rules="groups"><col width="27.83%" span="1"/><col width="15.55%" span="1"/><col width="14.5%" span="1"/><col width="20.62%" span="1"/><col width="21.5%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" colspan="1">Parameter</th><th colspan="2" valign="top" align="left" scope="colgroup" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1">Mean costs (SEM)</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">&#916; costs (95% CI)</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">&#916; costs (95% CI)</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1">Specialized orthotic care</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Usual orthotic care</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Unadjusted</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Adjusted</th></tr></thead><tbody><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1" colspan="1">Cost categories</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Lower limb orthosis</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2897 (325)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2104 (516)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">792 (-404; 1988)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">138 (-1541 to 1818)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Orthopedic shoes</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">587 (110)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">480 (138)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">107 (-238; 451)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-120 (-532; 291)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Walking aids</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">25 (17)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">17 (10)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">8 (-31; 47)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">8 (-31; 47)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">3D gait analyses</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2162 (93)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">90 (50)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2072 (1868; 2276)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2043 (1834; 2254)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Rehabilitation physicians</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">603 (61)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">218 (33)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">385 (243; 527)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">344 (201; 486)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Allied healthcare professionals</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">313 (113)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">564 (200)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-251 (-696; 193)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-511 (-1150; 127)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Total intervention costs</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">6587 (397)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3472 (552)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">3113 (1797; 4429)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1905 (602; 3207)*</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Primary healthcare costs</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">504 (124)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">856 (222)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-352 (-860; 157)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-483 (-1047; 81)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Secondary healthcare costs</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">838 (195)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">603 (205)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">235 (-343; 815)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-9 (-811; 793)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Medication</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">204 (97)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">321 (129)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-117 (-458; 225)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-145 (-531; 241)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Home care</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">134 (56)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">183 (82)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-50 (-249; 150)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-67 (-295; 160)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Total healthcare costs</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">8267 (522)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">5437 (784)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2830 (962; 4699)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1224 (-558; 3006)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Unpaid productivity <sup>a</sup></td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1514 (670)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2026 (664)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-512 (-2460; 1435)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-1508 (-3768; 752)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Absenteeism <sup>b</sup></td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">171 (150)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1029 (642)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-858 (-2150; 434)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-923 (-2215; 369)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Presenteeism <sup>c</sup></td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">2190 (858)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">6470 (1636)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-4280 (8095; -464)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-4669 (-9041; -301)*</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Informal care <sup>d</sup></td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">89 (46)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">245 (156)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-156 (-241; -53)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-239 (-330; -131)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Total societal costs</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">12231 (1185)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">15206 (2539)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-2975 (-8547; 2596)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-6029 (-12035; -23)*</td></tr></tbody></table><table-wrap-foot><p>CI: confidence interval; SEM: standard error of the mean.
<sup>a</sup> Related to productivity losses due to absence from work from unpaid activities; <sup>b</sup> related to productivity losses due to absence from work; <sup>c</sup> related to productivity losses due to being less productive at work; <sup>d</sup> related to unpaid assistance or support by <italic toggle="yes">e.g</italic>. family members.
*Significant difference, P&lt;0.05.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="tV" orientation="portrait"><label>Table V</label><caption><title><italic toggle="yes">&#8212;</italic>Summary of costs per cost-effectiveness results.</title></caption><table frame="hsides" rules="groups"><col width="42.31%" span="1"/><col width="22.38%" span="1"/><col width="22.37%" span="1"/><col width="12.94%" span="1"/><thead><tr><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Parameter</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Adjusted &#916; costs (95% CI)</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">&#916;E (95% CI)</th><th valign="top" align="left" scope="col" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">ICER</th></tr></thead><tbody><tr><td colspan="4" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Societal perspective</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Personal goal attainment (GAS)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-6029 (-12035; -23)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.33 (0.40; 2.25)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Energy cost of walking</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-6029 (-12035; -23)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.82 (-1.66; 0.02)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">QALYs</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-6029 (-12035; -23)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.13 (0.04; 0.22)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr><tr><td colspan="4" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Healthcare perspective</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Personal goal attainment (GAS)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1224 (-558; 3006)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.33 (0.40; 2.25)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">921</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Energy cost of walking</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1224 (-558; 3006)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.82 (-1.66; 0.02)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-1491</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">QALY</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1224 (-558; 3006)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.13 (0.04; 0.22)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">9263</td></tr><tr><td colspan="4" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Societal perspective: unadjusted for duration (sensitivity analysis)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Personal goal attainment (GAS)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-2429 (-7525; 2568)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.17 (0.19; 2.16)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Energy cost of walking</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-2429 (-7525; 2568)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.77 (-1.51; -0.02)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">QALY</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-2429 (-7525; 2568)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.14 (0.03; 0.24)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr><tr><td colspan="4" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Societal perspective: adjusted for work status (sensitivity analysis)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Personal goal attainment (GAS)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-2900 (-8533; 2733)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.33 (0.40; 2.25)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Energy cost of walking</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-2900 (-8533; 2733)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.82 (-1.66; 0.02)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">QALY</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-2900 (-8533; 2733)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.13 (0.04; 0.22)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr><tr><td colspan="4" valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="col" rowspan="1">Societal perspective: human capital approach (sensitivity analysis)</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Personal goal attainment (GAS)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-7116 (-14797; 457)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">1.33 (0.40; 2.25)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">Energy cost of walking</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-7116 (-14797; 457)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-0.82 (-1.66; 0.02)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr><tr><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" scope="row" rowspan="1" colspan="1">QALY</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">-7116 (-14797; 457)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">0.13 (0.04; 0.22)</td><td valign="top" align="left" style="border-left: solid 1pt; border-top: solid 1pt; border-right: solid 1pt; border-bottom: solid 1pt" rowspan="1" colspan="1">Dominant</td></tr></tbody></table><table-wrap-foot><p>CI: confidence interval; ICER: incremental cost-effectiveness ratio; QALY: quality-adjusted life years.
Dominant ICERs indicate cost-effective results, while the remaining ICERs indicate that cost-effectiveness should be assessed by comparing the ICER against established thresholds.</p></table-wrap-foot></table-wrap><p>The corresponding CEACs (Supplementary Digital Material 4: Supplementary Figure 1) show that the probability of specialized orthotic care being cost-effective compared to usual orthotic care for these outcomes is high, irrespective of the decision-makers&#8217; willingness-to-pay per unit of effect.</p><p>From the healthcare perspective, specialized orthotic care was on average more costly and more effective compared to usual orthotic care for QALYs, personal goal attainment and energy cost of walking (<xref rid="tIV" ref-type="table">Table IV, V</xref><xref rid="tV" ref-type="table"/>). The probability of specialized orthotic care being cost-effective compared to usual orthotic care was relatively high for these outcomes (Supplementary Figure 1).</p></sec><sec><title>Sensitivity analysis cost-effectiveness</title><p>Results of all sensitivity analyses (<xref rid="tIV" ref-type="table">Table IV, V</xref><xref rid="tV" ref-type="table"/>) were in line with the main analyses. That is, specialized orthotic care dominated usual orthotic care for all outcomes.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Our RCT showed that specialized orthotic care in expert settings was more effective compared to usual orthotic care in attaining personal goals in people with NMD, while energy cost of walking was not significantly different. Furthermore, specialized orthotic care improved perceived physical functioning more compared to usual orthotic care, as well as step length, and satisfaction. The economic evaluation showed that specialized orthotic care was cost-effective from a societal perspective, and presumably also from a healthcare perspective.</p><p>The higher goal attainment obtained with specialized orthotic care compared to usual orthotic care in our study indicates a positive impact on the individuals&#8217; performance on the ICF domains of activities and participation. The goal attainment we found following specialized orthotic care (median [IQR] first set GAS score: 0 [-1 to 1]), is similar to our previous finding in a retrospectively analyzed cohort of polio survivors who were clinically provided with specialist care orthoses (median [IQR] score: 0.5 [-1.25 to 0]).<xref rid="r20" ref-type="bibr"><sup>20</sup></xref> However, in that study, no follow-up measurement was available for a rather high number of participants (54%), which might have been partly attributed to poor treatment outcomes, possibly causing an effect overestimation. The superior effect of specialized orthotic care on daily life functioning as demonstrated with the GAS, is substantiated by the significant effect we found on perceived physical functioning, measured with the SF36-PF. This indicates that specialized orthotic care led to a more pronounced reduction in experienced limitations when engaging in various daily activities compared to usual orthotic care. However, changes in other aspects of perceived functioning such as pain and fatigue did not significantly differ between groups, while these aspects were sometimes included in the goals.</p><p>We found no significant effect on change in energy cost of walking for specialized orthotic care compared to usual care. However, the 11.8% reduction in energy cost following specialized care was significant (P=0.013) and of clinically relevant magnitude,<xref rid="r3" ref-type="bibr"><sup>3</sup></xref> whereas the reduction following usual orthotic care was only 1.7%. The absence of a significant between-group effect might be attributed to insufficient power, due to considerable variability in the energy cost data in both groups, especially in the intervention group (SD=2.36 J/kg/m), and that we did not fully achieve the required sample size (93% instead). The 11.8% reduction in energy cost of walking we found for specialist care orthoses stands in contrast to findings of our previous cohort study, in which we found no group-level reduction from clinically provided specialist care (SC)KAFOs and AFOs.<xref rid="r20" ref-type="bibr"><sup>20</sup></xref> Yet, in the latter study, a much larger number of participants was provided with (SC)KAFOs (70%), compared to that in the current RCT (5%). Yet, the subgroup in the cohort study that was provided with specialist care AFOs (N.=16) showed a similar reduction in energy cost (-9.5%) as observed in the specialized care group in this RCT. Compared to the cohort study, some of the current participants were provided with stiffness-optimized AFOs, a novel approach that reduces energy cost of walking to a greater extent than standard AFOs,<xref rid="r41" ref-type="bibr"><sup>41</sup></xref> which could explain the slightly larger effect found in the present study.</p><p>Despite expecting improved gait biomechanics to explain the reduction in walking energy cost following specialized compared to usual orthotic care, our findings only showed significant effects on walking speed and step length as measured during the gait analysis in favor of specialized care. The greater effect on step length could partly explain the effect on energy cost of walking, as studies assuming that persons minimize energy cost have shown that step length is one of the gait parameters impacting energy cost.<xref rid="r42" ref-type="bibr"><sup>42</sup></xref> However, no between-group effects on other biomechanical gait parameters were found. This could be attributed to heterogeneity of gait patterns at baseline between participants,<xref rid="r43" ref-type="bibr"><sup>43</sup></xref> as supported by large variability (shown by the SDs) in gait parameters. However, as changes in biomechanical gait parameters are essential in the understanding of our findings on energy cost, this needs further exploration in subgroups of individuals with similar gait patterns at baseline between groups. Regarding adverse events, the usual orthotic care group reported more incidents, primarily pressure sores, compared to the specialized orthotic care group. Despite the intervention group included more individuals with sensory deficits, typically associated with pressure-related issues, the greater proportion of prefabricated orthoses provided in usual orthotic care might have resulted in more pressure sores due to suboptimal fitting. All reported pressure sores were related to areas of contact with the orthosis, including the tibial region, heel, and areas under the toes. Possibly, the greater incidence of adverse events in the control group negatively impacted outcomes of physical functioning and satisfaction.</p><p>The economic evaluation showed that intervention costs of specialized orthotic care were significantly higher compared to those of usual orthotic care. This was anticipated due to higher costs of custom-made orthoses and routine conduct of a 3D gait analysis for diagnostics, optimization and evaluation. However, note that of the participants in the control group who received a (new) orthosis at their regular care center, 50% was provided with the same orthosis type. This likely minimized the frequency of required visits for orthotic care, consequently reducing associated costs. Nonetheless, as the specialized orthotic care group gained significantly more in QALYs and in primary effectiveness outcomes, probabilities of specialized orthotic care being cost-effective from a healthcare perspective were relatively high. The remarkably between-group difference in QALYs in favor of specialized orthotic care (+0.13; 95% CI: 0.04 to 0.22) was predominantly driven by mobility improvements, one of the five EQ-5D-5L dimensions, that assesses participants experienced walking problems. Societal costs were lower among participants receiving specialized orthotic care compared to usual care due to less informal care, unpaid productivity, and work-related absenteeism and presenteeism costs. This resulted in high probabilities of specialized orthotic care being cost-effective from the societal perspective compared to usual orthotic care.</p><sec><title>Limitations of the study</title><p>Our study provides a significant contribution to the field of orthotics in NMD as it is the first RCT that investigated the effectiveness and cost-effectiveness of lower limb orthoses on improving functioning in adults with NMD.<xref rid="r16" ref-type="bibr"><sup>16</sup></xref> Yet, several limitations should be mentioned. First, the usual orthotic care may have partly overlapped with the guideline-based approach in the two expertise settings, as the guideline is accessible for each health professional in the Netherlands. This could have reduced contrast between treatments and the certainty of effect sizes. Second, the COVID-19 pandemic, occurring in the second and third year of the study, not only impacted our recruitment and consequently the sample size, but it also strongly affected the participants&#8217; movement behavior. This might have influenced mobility outcomes possibly diminishing the differences observed between specialized and usual orthotic care. Nevertheless, since we anticipate that this impacted both groups similarly, we do not think this affected our conclusions. A further limitation is the heterogeneity of our study population, as we included various NMDs. However, since orthotic indication is based on muscle weakness rather than NMD type, this aligns with clinical practice. Additionally, as shown in <xref rid="tII" ref-type="table">Table II</xref>, muscle strength was similar between groups. Though, contrary to what was anticipated, we mostly included individuals who were indicated for an AFO. Therefore, we are unable to draw conclusions on effectiveness and cost-effectiveness of specialist care KAFOs, which warrants further research.</p></sec></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Our RCT in ambulant persons with NMD demonstrated that specialized orthotic care is beneficial in terms of attaining personal goals and likely cost-effective. Specialized orthotic care was also superior in improving perceived physical functioning. These results suggest that specialized orthotic care, <italic toggle="yes">i.e.</italic> guideline-based provision of lower limb orthoses in expert settings, could benefit functioning of persons with NMD. And, importantly, it could generate cost savings from a societal perspective.</p></sec><sec sec-type="supplementary-material|materials"><title>Supplementary Digital Material 1</title><supplementary-material position="float" content-type="local-data" orientation="portrait"><p>Supplementary Table I</p></supplementary-material><supplementary-material position="anchor" id="su1" content-type="local-data" orientation="portrait"><caption><p>Details on the specialized orthotic care process in terms of steps and visits according to the Process description for medical devices (see <xref rid="f1" ref-type="fig">Figure 1</xref>).</p></caption><media xlink:href="Supplementary_Digital_Material1.pdf" id="d67e2234" position="anchor" orientation="portrait"/></supplementary-material></sec><sec sec-type="supplementary-material|materials"><title>Supplementary Digital Material 2</title><supplementary-material position="float" content-type="local-data" orientation="portrait"><p>Supplementary Text File 1</p></supplementary-material><supplementary-material position="anchor" id="su2" content-type="local-data" orientation="portrait"><caption><p>Amsterdam UMC</p></caption><media xlink:href="Supplementary_Digital_Material2.pdf" id="d67e2242" position="anchor" orientation="portrait"/></supplementary-material></sec><sec sec-type="supplementary-material|materials"><title>Supplementary Digital Material 3</title><supplementary-material position="float" content-type="local-data" orientation="portrait"><p>Supplementary Table II</p></supplementary-material><supplementary-material position="anchor" id="su3" content-type="local-data" orientation="portrait"><caption><p>Provided lower limb orthoses during the course of the study.</p></caption><media xlink:href="Supplementary_Digital_Material3.pdf" id="d67e2250" position="anchor" orientation="portrait"/></supplementary-material></sec><sec sec-type="supplementary-material"><title>Supplementary Digital Material 4</title><supplementary-material position="float" content-type="local-data" orientation="portrait"><p>Supplementary Figure 1</p></supplementary-material><supplementary-material position="anchor" id="su4" content-type="local-data" orientation="portrait"><caption><p>Cost-effectiveness acceptability curves.</p></caption><media xlink:href="Supplementary_Digital_Material4.pdf" id="d67e2259" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><ack><title>Acknowledgements</title><p>The authors would like to thank the participating centers for their efforts with respect to the recruitment of participants, as well as the health practitioners involved in providing orthotic care for participants in the control and intervention groups. The authors acknowledge Marije Wolvers for her statistical support. Further, we acknowledge the help of Mirjam Wanders, Bert Brocking, Ronald Moerman, and Jan Bruggeman as orthotic users involved in the design of the study. Finally, they wish to thank everyone who helped with the data collection during the measurements of the study including Yikke Feenstra, Anna Voskuilen, Marit van der Veen, Hilde Ploeger, and Rein Miedema.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Conflicts of interest:</bold> The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> This study was supported by <funding-source rid="sp1">ZonMw, The Netherlands Organisation for Health Research and Development</funding-source> (grant number: <award-id rid="sp1">853001103</award-id>).</p></fn></fn-group><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brog&#229;rdh</surname><given-names>C</given-names></name><name name-style="western"><surname>Flansbjer</surname><given-names>UB</given-names></name><name name-style="western"><surname>Espelund</surname><given-names>C</given-names></name><name name-style="western"><surname>Lexell</surname><given-names>J</given-names></name></person-group>. <article-title>Relationship between self-reported walking ability and objectively assessed gait performance in persons with late effects of polio.</article-title><source>NeuroRehabilitation</source><year>2013</year>;<volume>33</volume>:<fpage>127</fpage>&#8211;<lpage>32</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=23949039&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=23949039&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.3233/NRE-130936</pub-id><pub-id pub-id-type="pmid">23949039</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Menotti</surname><given-names>F</given-names></name><name name-style="western"><surname>Felici</surname><given-names>F</given-names></name><name name-style="western"><surname>Damiani</surname><given-names>A</given-names></name><name name-style="western"><surname>Mangiola</surname><given-names>F</given-names></name><name name-style="western"><surname>Vannicelli</surname><given-names>R</given-names></name><name name-style="western"><surname>Macaluso</surname><given-names>A.</given-names></name></person-group><article-title>Charcot-Marie-Tooth 1A patients with low level of impairment have a higher energy cost of walking than healthy individuals.</article-title><source>Neuromuscul Disord</source><year>2011</year>;<volume>21</volume>:<fpage>52</fpage>&#8211;<lpage>7</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=21074996&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=21074996&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.nmd.2010.09.008</pub-id><pub-id pub-id-type="pmid">21074996</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brehm</surname><given-names>MA</given-names></name><name name-style="western"><surname>Nollet</surname><given-names>F</given-names></name><name name-style="western"><surname>Harlaar</surname><given-names>J</given-names></name></person-group>. <article-title>Energy demands of walking in persons with postpoliomyelitis syndrome: relationship with muscle strength and reproducibility.</article-title><source>Arch Phys Med Rehabil</source><year>2006</year>;<volume>87</volume>:<fpage>136</fpage>&#8211;<lpage>40</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16401452&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16401452&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.apmr.2005.08.123</pub-id><pub-id pub-id-type="pmid">16401452</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waterval</surname><given-names>NF</given-names></name><name name-style="western"><surname>Brehm</surname><given-names>MA</given-names></name><name name-style="western"><surname>Ploeger</surname><given-names>HE</given-names></name><name name-style="western"><surname>Nollet</surname><given-names>F</given-names></name><name name-style="western"><surname>Harlaar</surname><given-names>J</given-names></name></person-group>. <article-title>Compensations in lower limb joint work during walking in response to unilateral calf muscle weakness.</article-title><source>Gait Posture</source><year>2018</year>;<volume>66</volume>:<fpage>38</fpage>&#8211;<lpage>44</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=30145473&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=30145473&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.gaitpost.2018.08.016</pub-id><pub-id pub-id-type="pmid">30145473</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abresch</surname><given-names>RT</given-names></name><name name-style="western"><surname>Carter</surname><given-names>GT</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>MP</given-names></name><name name-style="western"><surname>Kilmer</surname><given-names>DD</given-names></name></person-group>. <article-title>Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease.</article-title><source>Am J Hosp Palliat Care</source><year>2002</year>;<volume>19</volume>:<fpage>39</fpage>&#8211;<lpage>48</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12173612&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12173612&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1177/104990910201900109</pub-id><pub-id pub-id-type="pmid">12173612</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burke</surname><given-names>K</given-names></name><name name-style="western"><surname>Cornell</surname><given-names>K</given-names></name><name name-style="western"><surname>Swartz Ellrodt</surname><given-names>A</given-names></name><name name-style="western"><surname>Grant</surname><given-names>N</given-names></name><name name-style="western"><surname>Paganono</surname><given-names>S</given-names></name><name name-style="western"><surname>Sadjadi</surname><given-names>R.</given-names></name></person-group><article-title>A pilot study to assess the immediate effect of carbon ground reaction ankle foot orthoses on balance in individuals with Charcot-Marie-Tooth in a clinical setting.</article-title><source>Phys Med Rehabil Int</source><year>2021</year>;<volume>8</volume>:<fpage>1183</fpage>.</mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hammar&#233;n</surname><given-names>E</given-names></name><name name-style="western"><surname>Kjellby-Wendt</surname><given-names>G</given-names></name><name name-style="western"><surname>Kowalski</surname><given-names>J</given-names></name><name name-style="western"><surname>Lindberg</surname><given-names>C</given-names></name></person-group>. <article-title>Factors of importance for dynamic balance impairment and frequency of falls in individuals with myotonic dystrophy type 1 - a cross-sectional study - including reference values of Timed Up &amp; Go, 10m walk and step test.</article-title><source>Neuromuscul Disord</source><year>2014</year>;<volume>24</volume>:<fpage>207</fpage>&#8211;<lpage>15</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=24412157&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=24412157&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.nmd.2013.12.003</pub-id><pub-id pub-id-type="pmid">24412157</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pieterse</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Luttikhold</surname><given-names>TB</given-names></name><name name-style="western"><surname>de Laat</surname><given-names>K</given-names></name><name name-style="western"><surname>Bloem</surname><given-names>BR</given-names></name><name name-style="western"><surname>van Engelen</surname><given-names>BG</given-names></name><name name-style="western"><surname>Munneke</surname><given-names>M</given-names></name></person-group>. <article-title>Falls in patients with neuromuscular disorders.</article-title><source>J Neurol Sci</source><year>2006</year>;<volume>251</volume>:<fpage>87</fpage>&#8211;<lpage>90</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17097113&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17097113&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.jns.2006.09.008</pub-id><pub-id pub-id-type="pmid">17097113</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brog&#229;rdh</surname><given-names>C</given-names></name><name name-style="western"><surname>Flansbjer</surname><given-names>UB</given-names></name><name name-style="western"><surname>Lexell</surname><given-names>J</given-names></name></person-group>. <article-title>Determinants of falls and fear of falling in ambulatory persons with late effects of polio.</article-title><source>PM R</source><year>2017</year>;<volume>9</volume>:<fpage>455</fpage>&#8211;<lpage>63</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=27546494&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=27546494&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.pmrj.2016.08.006</pub-id><pub-id pub-id-type="pmid">27546494</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahlstr&#246;m</surname><given-names>G</given-names></name><name name-style="western"><surname>Sj&#246;den</surname><given-names>PO</given-names></name></person-group>. <article-title>Coping with illness-related problems and quality of life in adult individuals with muscular dystrophy.</article-title><source>J Psychosom Res</source><year>1996</year>;<volume>41</volume>:<fpage>365</fpage>&#8211;<lpage>76</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8971667&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8971667&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/S0022-3999(96)00191-2</pub-id><pub-id pub-id-type="pmid">8971667</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>NE</given-names></name><name name-style="western"><surname>Heatwole</surname><given-names>CR</given-names></name><name name-style="western"><surname>Dilek</surname><given-names>N</given-names></name><name name-style="western"><surname>Sowden</surname><given-names>J</given-names></name><name name-style="western"><surname>Kirk</surname><given-names>CA</given-names></name><name name-style="western"><surname>Shereff</surname><given-names>D</given-names></name><etal/><collab>Inherited Neuropathies Consortium</collab></person-group>. <article-title>Quality-of-life in Charcot-Marie-Tooth disease: the patient&#8217;s perspective.</article-title><source>Neuromuscul Disord</source><year>2014</year>;<volume>24</volume>:<fpage>1018</fpage>&#8211;<lpage>23</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=25092060&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=25092060&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.nmd.2014.06.433</pub-id><pub-id pub-id-type="pmid">25092060</pub-id><pub-id pub-id-type="pmcid">PMC4253871</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perry</surname><given-names>J</given-names></name><name name-style="western"><surname>Clark</surname><given-names>D</given-names></name></person-group>. <article-title>Biomechanical abnormalities of post-polio patients and the implications for orthotic management.</article-title><source>NeuroRehabilitation</source><year>1997</year>;<volume>8</volume>:<fpage>119</fpage>&#8211;<lpage>38</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=24525982&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=24525982&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.3233/NRE-1997-8206</pub-id><pub-id pub-id-type="pmid">24525982</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="book">Hsu JD, Michael JW, Fisk JR. Atlas of orthoses and assistive devices. In: Atlas of Orthoses and Assistive Devices. Fourth edition. American Academy of Orthopedic Surgeons; 2008. p. 299&#8210;309.</mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choo</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Chang</surname><given-names>MC</given-names></name></person-group>. <article-title>Commonly Used Types and Recent Development of Ankle-Foot Orthosis: A Narrative Review.</article-title><source>Healthcare (Basel)</source><year>2021</year>;<volume>9</volume>:<fpage>1046</fpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=34442183&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=34442183&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.3390/healthcare9081046</pub-id><pub-id pub-id-type="pmid">34442183</pub-id><pub-id pub-id-type="pmcid">PMC8392067</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>F</given-names></name><name name-style="western"><surname>Hefzy</surname><given-names>MS</given-names></name><name name-style="western"><surname>Elahinia</surname><given-names>M</given-names></name></person-group>. <article-title>State of the art review of knee-ankle-foot orthoses.</article-title><source>Ann Biomed Eng</source><year>2015</year>;<volume>43</volume>:<fpage>427</fpage>&#8211;<lpage>41</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=25631201&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=25631201&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1007/s10439-014-1217-z</pub-id><pub-id pub-id-type="pmid">25631201</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="webpage">van der Wilk D, Dijkstra PU, Postema K, Verkerke GJ, Hijmans JM. Effects of ankle foot orthoses on body functions and activities in people with floppy paretic ankle muscles: a systematic review. Clin Biomech (Bristol) 2015;30:1009&#8211;25.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=26586583&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=26586583&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.clinbiomech.2015.09.013</pub-id><pub-id pub-id-type="pmid">26586583</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="other">van Duijnhoven E, Waterval NF, Koopman FS, Esquenazi A, Tyson S, Nollet F, Brehm MA. Ankle-foot orthoses for improving walking in people with calf muscle weakness due to neuromuscular disorders. Cochrane Database of Systematic Reviews 2021;(9).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD014871.pub2</pub-id><pub-id pub-id-type="pmcid">PMC11737026</pub-id><pub-id pub-id-type="pmid">39817620</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="webpage">Waterval NF, Brehm MA, Harlaar J, Nollet F. Description of orthotic properties and effect evaluation of ankle-foot orthoses in non-spastic calf muscle weakness. J Rehabil Med 2020;52:jrm00026.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=31934727&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=31934727&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.2340/16501977-2642</pub-id><pub-id pub-id-type="pmid">31934727</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="book">Brehm M, Nollet F. Beenorthesen bij neuromusculaire aandoeningen. StudieCloud; 2014.</mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Duijnhoven</surname><given-names>E</given-names></name><name name-style="western"><surname>Koopman</surname><given-names>FS</given-names></name><name name-style="western"><surname>Ploeger</surname><given-names>HE</given-names></name><name name-style="western"><surname>Nollet</surname><given-names>F</given-names></name><name name-style="western"><surname>Brehm</surname><given-names>MA</given-names></name></person-group>. <article-title>Effects of specialist care lower limb orthoses on personal goal attainment and walking ability in adults with neuromuscular disorders.</article-title><source>PLoS One</source><year>2023</year>;<volume>18</volume>:<elocation-id>e0279292</elocation-id>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=36652463&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=36652463&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1371/journal.pone.0279292</pub-id><pub-id pub-id-type="pmid">36652463</pub-id><pub-id pub-id-type="pmcid">PMC9847977</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Duijnhoven</surname><given-names>E</given-names></name><name name-style="western"><surname>Koopman</surname><given-names>FS</given-names></name><name name-style="western"><surname>Tuijtelaars</surname><given-names>JA</given-names></name><name name-style="western"><surname>Altmann</surname><given-names>V</given-names></name><name name-style="western"><surname>Lagrand</surname><given-names>R</given-names></name><name name-style="western"><surname>van Dongen</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Specialised orthotic care to improve functioning in adults with neuromuscular disorders: protocol of a prospective randomised open-label blinded end-point study.</article-title><source>BMJ Open</source><year>2020</year>;<volume>10</volume>:<elocation-id>e039683</elocation-id>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=33444196&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=33444196&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1136/bmjopen-2020-039683</pub-id><pub-id pub-id-type="pmcid">PMC7678344</pub-id><pub-id pub-id-type="pmid">33444196</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulz</surname><given-names>KF</given-names></name><name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name><name name-style="western"><surname>Moher</surname><given-names>D</given-names></name></person-group>. <article-title>CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.</article-title><source>J Pharmacol Pharmacother</source><year>2010</year>;<volume>1</volume>:<fpage>100</fpage>&#8211;<lpage>7</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=21350618&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=21350618&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.4103/0976-500X.72352</pub-id><pub-id pub-id-type="pmid">21350618</pub-id><pub-id pub-id-type="pmcid">PMC3043330</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>TA</given-names></name><name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name></person-group>. <article-title>Basic statistical reporting for articles published in biomedical journals: the &#8220;Statistical Analyses and Methods in the Published Literature&#8221; or the SAMPL Guidelines.</article-title><source>Int J Nurs Stud</source><year>2015</year>;<volume>52</volume>:<fpage>5</fpage>&#8211;<lpage>9</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=25441757&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=25441757&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.ijnurstu.2014.09.006</pub-id><pub-id pub-id-type="pmid">25441757</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Husereau</surname><given-names>D</given-names></name><name name-style="western"><surname>Drummond</surname><given-names>M</given-names></name><name name-style="western"><surname>Augustovski</surname><given-names>F</given-names></name><name name-style="western"><surname>de Bekker-Grob</surname><given-names>E</given-names></name><name name-style="western"><surname>Briggs</surname><given-names>AH</given-names></name><name name-style="western"><surname>Carswell</surname><given-names>C</given-names></name><etal/></person-group>; <article-title>CHEERS 2022 ISPOR Good Research Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.</article-title><source>Value Health</source><year>2022</year>;<volume>25</volume>:<fpage>3</fpage>&#8211;<lpage>9</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=35031096&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=35031096&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.jval.2021.11.1351</pub-id><pub-id pub-id-type="pmid">35031096</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="book">Zorgverzekeringen&#8217; Cv. Procesbeschrijving hulpmiddelenzorg. Den Haag: Nationaal ICT Instituut in de Zorg; 2009.</mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="book">Kendall F, Kendall M, Provance P, Rodgers M, Romani W. Muscles: Testing and Function with Posture and Pain. Baltimore, MD: Wolters Kluwer; 2005.</mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="webpage">Dekkers K, de Viet E, Eilander H, Steenbeek D. Goal attainment scaling (GAS) in de praktijk; 2011 [Internet]. Available from: <ext-link xlink:href="https://revant.nl/dynamic/media/1/documents/Gas/handleiding_GAS.pdf" ext-link-type="uri">https://revant.nl/dynamic/media/1/documents/Gas/handleiding_GAS.pdf</ext-link> [cited 2025, Jul 8].</mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steenbeek</surname><given-names>D</given-names></name><name name-style="western"><surname>Meester-Delver</surname><given-names>A</given-names></name><name name-style="western"><surname>Becher</surname><given-names>JG</given-names></name><name name-style="western"><surname>Lankhorst</surname><given-names>GJ</given-names></name></person-group>. <article-title>The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: evaluation with goal attainment scaling.</article-title><source>Clin Rehabil</source><year>2005</year>;<volume>19</volume>:<fpage>274</fpage>&#8211;<lpage>82</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15859528&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15859528&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1191/0269215505cr859oa</pub-id><pub-id pub-id-type="pmid">15859528</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="book">World Health Organization. International classification of functioning, disability and health: ICF. Geneva: World Health Organization; 2001.</mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garby</surname><given-names>L</given-names></name><name name-style="western"><surname>Astrup</surname><given-names>A</given-names></name></person-group>. <article-title>The relationship between the respiratory quotient and the energy equivalent of oxygen during simultaneous glucose and lipid oxidation and lipogenesis.</article-title><source>Acta Physiol Scand</source><year>1987</year>;<volume>129</volume>:<fpage>443</fpage>&#8211;<lpage>4</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=3577829&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=3577829&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1111/j.1365-201X.1987.tb10613.x</pub-id><pub-id pub-id-type="pmid">3577829</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aaronson</surname><given-names>NK</given-names></name><name name-style="western"><surname>Muller</surname><given-names>M</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>PD</given-names></name><name name-style="western"><surname>Essink-Bot</surname><given-names>ML</given-names></name><name name-style="western"><surname>Fekkes</surname><given-names>M</given-names></name><name name-style="western"><surname>Sanderman</surname><given-names>R</given-names></name><etal/></person-group><article-title>Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.</article-title><source>J Clin Epidemiol</source><year>1998</year>;<volume>51</volume>:<fpage>1055</fpage>&#8211;<lpage>68</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9817123&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9817123&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/S0895-4356(98)00097-3</pub-id><pub-id pub-id-type="pmid">9817123</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kempen</surname><given-names>GI</given-names></name><name name-style="western"><surname>Yardley</surname><given-names>L</given-names></name><name name-style="western"><surname>van Haastregt</surname><given-names>JC</given-names></name><name name-style="western"><surname>Zijlstra</surname><given-names>GA</given-names></name><name name-style="western"><surname>Beyer</surname><given-names>N</given-names></name><name name-style="western"><surname>Hauer</surname><given-names>K</given-names></name><etal/></person-group><article-title>The Short FES-I: a shortened version of the falls efficacy scale-international to assess fear of falling.</article-title><source>Age Ageing</source><year>2008</year>;<volume>37</volume>:<fpage>45</fpage>&#8211;<lpage>50</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=18032400&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=18032400&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1093/ageing/afm157</pub-id><pub-id pub-id-type="pmid">18032400</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rietberg</surname><given-names>MB</given-names></name><name name-style="western"><surname>Van Wegen</surname><given-names>EE</given-names></name><name name-style="western"><surname>Kwakkel</surname><given-names>G</given-names></name></person-group>. <article-title>Measuring fatigue in patients with multiple sclerosis: reproducibility, responsiveness and concurrent validity of three Dutch self-report questionnaires.</article-title><source>Disabil Rehabil</source><year>2010</year>;<volume>32</volume>:<fpage>1870</fpage>&#8211;<lpage>6</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=20345240&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=20345240&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.3109/09638281003734458</pub-id><pub-id pub-id-type="pmid">20345240</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wessels</surname><given-names>RD</given-names></name><name name-style="western"><surname>De Witte</surname><given-names>LP</given-names></name></person-group>. <article-title>Reliability and validity of the Dutch version of QUEST 2.0 with users of various types of assistive devices.</article-title><source>Disabil Rehabil</source><year>2003</year>;<volume>25</volume>:<fpage>267</fpage>&#8211;<lpage>72</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12623616&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12623616&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1080/0963828021000031197</pub-id><pub-id pub-id-type="pmid">12623616</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanters</surname><given-names>TA</given-names></name><name name-style="western"><surname>Bouwmans</surname><given-names>CA</given-names></name><name name-style="western"><surname>van der Linden</surname><given-names>N</given-names></name><name name-style="western"><surname>Tan</surname><given-names>SS</given-names></name><name name-style="western"><surname>Hakkaart-van Roijen</surname><given-names>L</given-names></name></person-group>. <article-title>Update of the Dutch manual for costing studies in health care.</article-title><source>PLoS One</source><year>2017</year>;<volume>12</volume>:<elocation-id>e0187477</elocation-id>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=29121647&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=29121647&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1371/journal.pone.0187477</pub-id><pub-id pub-id-type="pmid">29121647</pub-id><pub-id pub-id-type="pmcid">PMC5679627</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herdman</surname><given-names>M</given-names></name><name name-style="western"><surname>Gudex</surname><given-names>C</given-names></name><name name-style="western"><surname>Lloyd</surname><given-names>A</given-names></name><name name-style="western"><surname>Janssen</surname><given-names>M</given-names></name><name name-style="western"><surname>Kind</surname><given-names>P</given-names></name><name name-style="western"><surname>Parkin</surname><given-names>D</given-names></name><etal/></person-group><article-title>Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).</article-title><source>Qual Life Res</source><year>2011</year>;<volume>20</volume>:<fpage>1727</fpage>&#8211;<lpage>36</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=21479777&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=21479777&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1007/s11136-011-9903-x</pub-id><pub-id pub-id-type="pmid">21479777</pub-id><pub-id pub-id-type="pmcid">PMC3220807</pub-id></mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>M Versteegh M</collab></person-group>, <article-title>M Vermeulen K, M A A Evers S, de Wit GA, Prenger R, A Stolk E. Dutch tariff for the five-level version of EQ-5D.</article-title><source>Value Health</source><year>2016</year>;<volume>19</volume>:<fpage>343</fpage>&#8211;<lpage>52</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=27325326&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=27325326&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.jval.2016.01.003</pub-id><pub-id pub-id-type="pmid">27325326</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brehm</surname><given-names>MA</given-names></name><name name-style="western"><surname>Beelen</surname><given-names>A</given-names></name><name name-style="western"><surname>Doorenbosch</surname><given-names>CA</given-names></name><name name-style="western"><surname>Harlaar</surname><given-names>J</given-names></name><name name-style="western"><surname>Nollet</surname><given-names>F</given-names></name></person-group>. <article-title>Effect of carbon-composite knee-ankle-foot orthoses on walking efficiency and gait in former polio patients.</article-title><source>J Rehabil Med</source><year>2007</year>;<volume>39</volume>:<fpage>651</fpage>&#8211;<lpage>7</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17896058&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17896058&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.2340/16501977-0110</pub-id><pub-id pub-id-type="pmid">17896058</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben</surname><given-names>&#194;J</given-names></name><name name-style="western"><surname>van Dongen</surname><given-names>JM</given-names></name><name name-style="western"><surname>El Alili</surname><given-names>M</given-names></name><name name-style="western"><surname>Esser</surname><given-names>JL</given-names></name><name name-style="western"><surname>Broul&#237;kov&#225;</surname><given-names>HM</given-names></name><name name-style="western"><surname>Bosmans</surname><given-names>JE</given-names></name></person-group>. <article-title>Conducting Trial-Based Economic Evaluations Using R: A Tutorial.</article-title><source>PharmacoEconomics</source><year>2023</year>;<volume>41</volume>:<fpage>1403</fpage>&#8211;<lpage>13</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=37458913&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=37458913&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1007/s40273-023-01301-7</pub-id><pub-id pub-id-type="pmid">37458913</pub-id><pub-id pub-id-type="pmcid">PMC10570221</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>IR</given-names></name><name name-style="western"><surname>Royston</surname><given-names>P</given-names></name><name name-style="western"><surname>Wood</surname><given-names>AM</given-names></name></person-group>. <article-title>Multiple imputation using chained equations: issues and guidance for practice.</article-title><source>Stat Med</source><year>2011</year>;<volume>30</volume>:<fpage>377</fpage>&#8211;<lpage>99</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=21225900&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=21225900&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1002/sim.4067</pub-id><pub-id pub-id-type="pmid">21225900</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waterval</surname><given-names>NF</given-names></name><name name-style="western"><surname>Brehm</surname><given-names>MA</given-names></name><name name-style="western"><surname>Altmann</surname><given-names>VC</given-names></name><name name-style="western"><surname>Koopman</surname><given-names>FS</given-names></name><name name-style="western"><surname>Den Boer</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Harlaar</surname><given-names>J</given-names></name><etal/></person-group><article-title>Stiffness-Optimized Ankle-Foot Orthoses Improve Walking Energy Cost Compared to Conventional Orthoses in Neuromuscular Disorders: A Prospective Uncontrolled Intervention Study.</article-title><source>IEEE Trans Neural Syst Rehabil Eng</source><year>2020</year>;<volume>28</volume>:<fpage>2296</fpage>&#8211;<lpage>304</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=32833637&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=32833637&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1109/TNSRE.2020.3018786</pub-id><pub-id pub-id-type="pmid">32833637</pub-id></mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bertram</surname><given-names>JE</given-names></name></person-group>. <article-title>Constrained optimization in human walking: cost minimization and gait plasticity.</article-title><source>J Exp Biol</source><year>2005</year>;<volume>208</volume>:<fpage>979</fpage>&#8211;<lpage>91</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15767300&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15767300&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1242/jeb.01498</pub-id><pub-id pub-id-type="pmid">15767300</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ploeger</surname><given-names>HE</given-names></name><name name-style="western"><surname>Bus</surname><given-names>SA</given-names></name><name name-style="western"><surname>Nollet</surname><given-names>F</given-names></name><name name-style="western"><surname>Brehm</surname><given-names>MA</given-names></name></person-group>. <article-title>Gait patterns in association with underlying impairments in polio survivors with calf muscle weakness.</article-title><source>Gait Posture</source><year>2017</year>;<volume>58</volume>:<fpage>146</fpage>&#8211;<lpage>53</lpage>.<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=28779720&amp;dopt=Abstract" ext-link-type="uri"> https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=28779720&amp;dopt=Abstract</ext-link><pub-id pub-id-type="doi">10.1016/j.gaitpost.2017.07.107</pub-id><pub-id pub-id-type="pmid">28779720</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>